marketcaparena
Search

    VTGN

    Vistagen Therapeutics, Inc.

    Company overview

    Market capitalization
    $13.18M
    Employees
    41
    Latest publication
    2026-09-29
    About Vistagen Therapeutics, Inc.

    Vistagen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders. The company's product pipeline includes Fasedienol, an investigational pherine nasal spray that is in Phase III clinical trial for the treatment of anxiety in adults with social anxiety disorder; and Itruvone, an odorless synthetic investigational neuroactive pherine nasal spray, which is in Phase IIa clinical trial to treat major depressive disorder. It also develops refisolone, an odorless and tasteless synthetic investigational pherine nasal spray that is in Phase IIa clinical trial for the treatment of vasomotor symptoms, including hot flashes due to menopause, premenstrual dysphoric disorder, and other women's health disorders; PH15, an investigational pherine nasal spray, which is in Phase IIa clinical trial for the treatment to improve cognitive impairment caused by mental fatigue disorders; PH284, an odorless and tasteless synthetic investigational pherine nasal spray that is in Phase IIa clinical trial to treat loss of appetite associated with chronic disorders, such as cancer cachexia; and AV-101, an oral prodrug that targets N-methyl-D-aspartate receptor in the brain for treating depression and neurological disorders. It has a license and collaboration agreement with AffaMed Therapeutics, Inc. to develop, manufacture, and commercialize fasedienol for multiple anxiety-related disorders. Vistagen Therapeutics, Inc. was founded in 1998 and is headquartered in South San Francisco, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-06-30 · USDQ4 20262026-03-31 · USDQ3 20262025-12-31 · USDQ2 20262025-09-30 · USDQ4 20252025-03-31 · USDQ2 20252024-09-30 · USDQ1 20252024-06-30 · USDQ4 20242024-03-31 · USD
    Total Revenue1,476,000USD465,000USD303,000USD258,000USD-15,000USD183,000USD84,000USD197,300USD
    Research Development10,906,000USD13,060,000USD14,169,000USD15,915,000USD10,207,000USD10,215,000USD7,648,000USD7,436,600USD
    Selling General Administrative3,918,000USD4,122,000USD5,491,000USD4,396,000USD4,273,000USD4,195,000USD4,567,000USD4,120,000USD
    General And Administrative Expenses3,918,000USD———————
    Total Operating Expenses14,824,000USD17,182,000USD19,660,000USD20,311,000USD14,480,000USD14,410,000USD12,215,000USD11,556,300USD
    Operating Income-13,348,000USD-16,717,000USD-19,546,000USD-20,053,000USD-14,495,000USD-14,227,000USD-12,131,000USD-11,359,000USD
    Total Other Income Expense Net318,000USD450,000USD647,000USD636,000USD860,000USD1,273,000USD1,398,000USD1,839,100USD
    Income Before Tax-13,030,000USD-16,267,000USD-18,899,000USD-19,417,000USD-13,635,000USD-12,954,000USD-10,733,000USD-9,519,900USD
    Income Tax Expense0USD7,000USD———7,000USD-151,000USD1,500USD
    Net Income-13,030,000USD-16,274,000USD-18,899,000USD-19,417,000USD-13,635,000USD-12,961,000USD-10,733,000USD-9,521,400USD
    Cost Of Revenue—389,000USD189,000USD—161,000USD157,000USD151,000USD146,500USD
    Gross Profit—465,000USD114,000USD258,000USD-15,000USD183,000USD84,000USD197,300USD
    Interest Income—452,000USD647,000USD630,000USD855,000USD1,273,000USD1,398,000USD—
    Net Interest Income—452,000USD647,000USD630,000USD855,000USD1,273,000USD1,398,000USD1,527,100USD
    Tax Provision—7,000USD0USD0USD0USD7,000USD0USD1,500USD
    Net Income From Continuing Ops—-16,274,000USD-18,899,000USD-19,417,000USD-13,635,000USD-12,961,000USD-10,733,000USD-9,521,400USD
    Ebit—-16,717,000USD-18,899,000USD-19,417,000USD-13,635,000USD-12,954,000USD-10,733,000USD-11,359,300USD
    Ebitda—-16,527,000USD-18,710,000USD-19,232,000USD-13,469,000USD-12,797,000USD-10,582,000USD-11,212,800USD
    Depreciation And Amortization—190,000USD189,000USD185,000USD166,000USD157,000USD151,000USD146,500USD
    Reconciled Depreciation—190,000USD189,000USD185,000USD166,000USD157,000USD151,000USD146,500USD
    Selling And Marketing Expenses———————146,800USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20262026-03-31 · USDFY 20252025-03-31 · USDFY 20242024-03-31 · USDFY 20232023-03-31 · USDFY 20222022-03-31 · USDFY 20212021-03-31 · USDFY 20202020-03-31 · USDFY 20192019-03-31 · USD
    Total Revenue1,269,000USD486,000USD1,064,000USD-227,300USD1,108,900USD1,089,500USD334,000USD0USD
    Gross Profit1,269,000USD486,000USD1,064,000USD-227,300USD1,108,900USD1,089,500USD-103,100USD-91,200USD
    Research Development54,974,000USD39,375,000USD20,022,000USD44,377,100USD35,407,800USD11,925,700USD13,325,200USD17,098,500USD
    Selling General Administrative18,421,000USD17,084,000USD14,063,000USD14,663,600USD10,452,000USD7,098,000USD6,600,000USD7,432,000USD
    Total Operating Expenses73,395,000USD56,459,000USD34,085,000USD59,040,700USD48,887,800USD19,023,300USD19,871,400USD24,530,500USD
    Operating Income-72,126,000USD-55,973,000USD-33,021,000USD-59,268,000USD-47,778,900USD-17,933,800USD-19,974,500USD-24,556,300USD
    Interest Income2,441,000USD4,557,000USD3,351,000USD26,200USD20,000USD15,000USD45,000USD8,000USD
    Net Interest Income2,441,000USD4,557,000USD3,351,000USD26,200USD20,000USD2,000USD30,000USD-8,000USD
    Income Before Tax-69,678,000USD-51,411,000USD-29,358,000USD-59,241,800USD-47,759,000USD-17,931,600USD-20,771,400USD-24,587,000USD
    Income Tax Expense7,000USD7,000USD4,000USD5,900USD3,400USD2,600USD2,600USD2,600USD
    Tax Provision7,000USD7,000USD4,000USD5,900USD3,400USD2,600USD2,600USD2,600USD
    Net Income-69,685,000USD-51,418,000USD-29,362,000USD-59,247,700USD-47,762,400USD-17,934,200USD-20,774,000USD-24,589,600USD
    Net Income From Continuing Ops-69,685,000USD-51,418,000USD-29,362,000USD-59,247,700USD-47,762,400USD-17,934,200USD-20,774,000USD-24,589,600USD
    Ebit-72,126,000USD-51,411,000USD-29,358,000USD-59,268,000USD-47,759,000USD-17,918,600USD-20,756,400USD-24,556,300USD
    Ebitda-71,393,000USD-50,776,000USD-28,790,000USD-58,736,800USD-47,047,900USD-17,441,000USD-20,653,300USD-24,465,100USD
    Depreciation And Amortization733,000USD635,000USD568,000USD531,200USD711,100USD477,600USD103,100USD91,200USD
    Reconciled Depreciation733,000USD635,000USD568,000USD531,200USD711,100USD117,600USD103,100USD91,200USD
    Total Other Income Expense Net2,448,000USD4,562,000USD3,663,000USD26,200USD19,900USD2,200USD-796,900USD-30,700USD
    Cost Of Revenue—635,000USD568,000USD509,800USD815,200USD—103,100USD91,200USD
    Interest Expense———23,000USD232,000USD13,000USD15,000USD8,000USD
    Net Income Applicable To Common Shares———-59,247,700USD-48,707,500USD-42,319,800USD-22,037,600USD-25,729,500USD
    Selling And Marketing Expenses————2,796,000USD———
    Non Operating Income Net Other———————-22,700USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-06-30 · USDQ4 20262026-03-31 · USDQ3 20262025-12-31 · USDQ2 20262025-09-30 · USDQ4 20252025-03-31 · USDQ3 20252024-12-31 · USDQ2 20252024-09-30 · USDQ1 20252024-06-30 · USD
    Total Assets35,736,000USD48,564,000USD65,056,000USD80,929,000USD84,341,000USD92,307,000USD102,496,000USD113,548,000USD
    Cash And Equivalents16,991,000USD———————
    Total Current Assets34,310,000USD46,943,000USD63,245,000USD78,934,000USD82,076,000USD89,941,000USD99,948,000USD110,838,000USD
    Other Current Assets2,580,000USD1,540,000USD1,475,000USD1,759,000USD1,594,000USD1,381,000USD2,370,000USD2,474,000USD
    Other Non Current Assets392,000USD———————
    Total Liabilities11,255,000USD———————
    Total Current Liabilities11,192,000USD12,795,000USD13,529,000USD13,644,000USD12,612,000USD9,621,000USD7,523,000USD6,236,000USD
    Other Current Liabilities9,238,000USD———————
    Total Stockholder Equity24,481,000USD35,520,000USD50,920,000USD66,339,000USD70,390,000USD81,122,000USD92,974,000USD104,803,000USD
    Total Equity Including Noncontrolling Interest24,481,000USD———————
    Deferred Revenue234,000USD———————
    Deferred Revenue Non Current0USD———————
    Property Plant Equipment Net1,034,000USD1,228,000USD1,419,000USD1,590,000USD1,811,000USD1,889,000USD2,050,000USD2,192,000USD
    Accounts Payable1,000,000USD1,535,000USD1,280,000USD1,831,000USD653,000USD1,039,000USD715,000USD1,209,000USD
    Short Term Debt720,000USD795,000USD996,000USD1,255,000USD561,000USD603,000USD525,000USD567,000USD
    Common Stock44,000USD40,000USD40,000USD39,000USD29,000USD28,000USD27,000USD27,000USD
    Retained Earnings-490,347,000USD-477,317,000USD-461,043,000USD-442,144,000USD-407,632,000USD-393,997,000USD-379,908,000USD-366,947,000USD
    Accumulated Other Comprehensive Income-7,000USD-2,000USD13,000USD14,000USD5,000USD11,000USD22,000USD2,000USD
    Total Liab—13,044,000USD14,136,000USD14,590,000USD13,951,000USD11,185,000USD9,522,000USD8,745,000USD
    Other Current Liab—8,755,000USD9,254,000USD8,417,000USD8,810,000USD5,469,000USD3,815,000USD2,164,000USD
    Capital Stock—40,000USD40,000USD39,000USD29,000USD28,000USD27,000USD27,000USD
    Cash—30,789,000USD47,371,000USD62,786,000USD67,131,000USD74,715,000USD84,246,000USD102,918,000USD
    Cash And Short Term Investments—45,403,000USD61,770,000USD77,175,000USD80,482,000USD88,560,000USD97,578,000USD108,364,000USD
    Current Deferred Revenue—1,710,000USD1,999,000USD2,141,000USD2,588,000USD2,510,000USD2,468,000USD2,296,000USD
    Net Debt—-29,745,000USD-45,944,000USD-60,921,000USD-65,622,000USD-73,002,000USD-82,452,000USD-100,928,000USD
    Short Long Term Debt—96,000USD379,000USD658,000USD————
    Short Long Term Debt Total—1,044,000USD1,427,000USD1,865,000USD1,509,000USD1,713,000USD1,794,000USD1,990,000USD
    Short Term Investments—14,614,000USD14,399,000USD14,389,000USD13,351,000USD13,845,000USD13,332,000USD5,446,000USD
    Property Plant Equipment Gross—2,301,000USD1,419,000USD1,590,000USD3,215,000USD1,889,000USD2,050,000USD2,192,000USD
    Common Stock Shares Outstanding—38,073,926shares42,234,405shares35,749,160shares30,711,872shares30,711,872shares30,632,347shares30,603,435shares
    Non Current Assets Total—1,621,000USD1,811,000USD1,995,000USD2,265,000USD2,366,000USD2,548,000USD2,710,000USD
    Non Current Liabilities Total—249,000USD607,000USD946,000USD1,339,000USD1,564,000USD1,999,000USD2,509,000USD
    Non Currrent Assets Other—393,000USD392,000USD405,000USD454,000USD477,000USD498,000USD518,000USD
    Net Working Capital—34,148,000USD49,716,000USD65,290,000USD69,464,000USD80,320,000USD92,425,000USD104,602,000USD
    Unclassified Equity—512,759,000USD511,870,000USD508,391,000USD477,959,000USD475,052,000USD472,806,000USD471,694,000USD
    Unclassified Non Current Liabilities————1,339,000USD1,564,000USD1,999,000USD2,509,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20262026-03-31 · USDFY 20252025-03-31 · USDFY 20242024-03-31 · USDFY 20232023-03-31 · USDFY 20222022-03-31 · USDFY 20212021-03-31 · USDFY 20202020-03-31 · USDFY 20192019-03-31 · USD
    Total Assets48,564,000USD84,341,000USD123,653,000USD21,089,000USD74,643,400USD108,281,300USD5,772,300USD14,011,700USD
    Other Current Assets1,540,000USD1,594,000USD3,012,000USD272,300USD116,900USD968,600USD225,100USD250,900USD
    Total Liab13,044,000USD13,951,000USD9,367,000USD9,009,000USD9,928,100USD16,302,800USD11,501,700USD6,936,500USD
    Total Stockholder Equity35,520,000USD70,390,000USD114,286,000USD12,080,000USD64,715,300USD91,978,500USD-5,729,400USD7,075,200USD
    Other Current Liab8,755,000USD8,810,000USD2,235,000USD796,000USD1,329,200USD3,125,400USD561,500USD1,685,600USD
    Common Stock40,000USD29,000USD27,000USD7,000USD6,900USD180,800USD49,300USD42,800USD
    Capital Stock40,000USD29,000USD27,000USD7,300USD206,700USD185,100USD53,300USD46,800USD
    Retained Earnings-477,317,000USD-407,632,000USD-356,214,000USD-326,852,000USD-267,604,000USD-219,841,600USD-201,907,400USD-181,133,400USD
    Cash30,789,000USD67,131,000USD119,166,000USD16,638,000USD68,135,300USD103,108,300USD1,355,100USD13,100,300USD
    Cash And Short Term Investments45,403,000USD80,482,000USD119,166,000USD16,638,000USD68,135,300USD103,108,300USD1,355,100USD13,100,300USD
    Total Current Assets46,943,000USD82,076,000USD120,672,000USD17,507,000USD70,998,000USD104,117,500USD1,580,200USD13,651,200USD
    Total Current Liabilities12,795,000USD12,612,000USD5,123,000USD4,574,000USD5,765,100USD4,189,000USD2,771,300USD2,800,900USD
    Current Deferred Revenue1,710,000USD2,588,000USD791,000USD714,000USD1,244,000USD1,420,200USD——
    Net Debt-29,745,000USD-65,622,000USD-117,046,000USD-13,927,000USD-65,096,600USD-99,389,700USD2,736,700USD-13,033,700USD
    Short Term Debt795,000USD561,000USD550,000USD591,000USD433,300USD367,800USD373,200USD60,300USD
    Short Long Term Debt96,000USD——105,300USD——56,500USD57,300USD
    Short Long Term Debt Total1,044,000USD1,509,000USD2,120,000USD2,711,000USD3,038,700USD3,718,600USD4,091,800USD66,600USD
    Short Term Investments14,614,000USD13,351,000USD0USD—————
    Accounts Payable1,535,000USD653,000USD1,547,000USD2,473,000USD2,758,600USD838,300USD1,836,600USD1,055,000USD
    Property Plant Equipment Net1,228,000USD1,811,000USD2,255,000USD2,767,000USD3,076,300USD3,587,000USD3,789,200USD312,700USD
    Property Plant Equipment Gross2,301,000USD3,215,000USD3,509,000USD2,767,600USD4,345,100USD3,587,000USD3,789,200USD312,700USD
    Accumulated Other Comprehensive Income-2,000USD5,000USD0USD0USD0USD0USD0USD-4,000USD
    Common Stock Shares Outstanding38,073,926shares30,711,872shares19,354,500shares6,958,818shares6,599,286shares2,871,121shares1,462,317shares952,082shares
    Non Current Assets Total1,621,000USD2,265,000USD2,981,000USD3,582,000USD3,645,400USD4,163,800USD4,192,100USD360,500USD
    Non Current Liabilities Total249,000USD1,339,000USD4,244,000USD4,435,000USD4,163,000USD12,113,800USD8,730,400USD4,135,600USD
    Non Currrent Assets Other393,000USD454,000USD726,000USD815,000USD569,100USD576,800USD402,900USD47,800USD
    Net Working Capital34,148,000USD69,464,000USD115,549,000USD12,940,000USD65,232,900USD99,928,500USD-1,191,100USD10,850,300USD
    Unclassified Equity512,759,000USD477,959,000USD470,446,000USD338,917,700USD336,073,800USD315,422,300USD200,043,500USD192,091,100USD
    Unclassified Non Current Liabilities—1,339,000USD4,244,000USD1,407,100USD-2,025,800USD———
    Unclassified Current Assets——-1,506,000USD—-2,453,000USD———
    Deferred Long Term Liab———713,300USD468,200USD529,000USD355,100USD22,300USD
    Other Liab———2,314,600USD1,557,600USD2,490,300USD—381,100USD
    Other Assets———814,200USD569,100USD576,800USD402,900USD70,100USD
    Net Receivables———802,700USD2,745,800USD40,600USD—300,000USD
    Inventory———-735,600USD2,453,000USD942,200USD—230,400USD
    Net Tangible Assets———12,080,000USD64,715,300USD91,974,200USD-5,733,400USD7,071,200USD
    Treasury Stock————-3,968,100USD-3,968,100USD-3,968,100USD-3,968,100USD
    Non Current Liabilities Other————4,163,000USD9,623,500USD8,730,400USD3,748,200USD
    Unclassified Current Liabilities—————-1,562,700USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-06-30 · USDQ4 20262026-03-31 · USDQ3 20262025-12-31 · USDQ2 20262025-09-30 · USDQ4 20252025-03-31 · USDQ3 20252024-12-31 · USDQ2 20252024-09-30 · USDQ1 20252024-06-30 · USD
    Depreciation52,000USD190,000USD189,000USD185,000USD166,000USD161,000USD157,000USD151,000USD
    Stock Based Compensation991,000USD889,000USD1,096,000USD1,096,000USD963,000USD1,080,000USD1,112,000USD1,160,000USD
    Change To Liabilities-53,000USD———————
    Change In Working Capital-1,114,000USD-873,000USD126,000USD4,523,000USD2,572,000USD2,670,000USD946,000USD-1,428,000USD
    Operating Cash Flow-14,707,000USD———————
    Net Investments0USD———————
    Investing Cash Flow0USD———————
    Common Stock Issuance74,000USD———————
    Unclassified Financing Cash Flow835,000USD—-2,042,000USD-27,654,000USD———5,467,000USD
    Financing Cash Flow909,000USD———————
    Change In Cash-13,798,000USD-16,582,000USD-15,415,000USD13,801,000USD-7,584,000USD-9,531,000USD-18,672,000USD-16,248,000USD
    End Cash Flow16,991,000USD———————
    Net Income—-16,274,000USD-18,899,000USD-19,417,000USD-13,635,000USD-14,089,000USD-12,961,000USD-10,733,000USD
    Other Non Cash Items—-132,000USD-143,000USD-146,000USD-128,000USD-102,000USD-140,000USD-19,000USD
    Total Cash From Operating Activities—-16,200,000USD-17,631,000USD-13,759,000USD-10,062,000USD-10,280,000USD-10,886,000USD-10,869,000USD
    Capital Expenditures—-125,000USD-60,000USD-60,000USD-88,000USD0USD-42,000USD-42,000USD
    Free Cash Flow—-16,200,000USD-17,571,000USD-13,819,000USD-10,150,000USD-10,280,000USD-10,844,000USD-10,911,000USD
    Investments—-99,000USD130,000USD-94,000USD527,000USD-422,000USD-7,786,000USD-5,467,000USD
    Total Cashflows From Investing Activities—-99,000USD104,000USD-94,000USD527,000USD-422,000USD-7,786,000USD-5,467,000USD
    Net Borrowings—-283,000USD-278,000USD-274,000USD0USD0USD0USD—
    Total Cash From Financing Activities—-283,000USD2,112,000USD27,654,000USD1,951,000USD1,171,000USD0USD88,000USD
    Issuance Of Capital Stock—0USD2,320,000USD27,928,000USD1,951,000USD1,058,000USD-88,000USD88,000USD
    Begin Period Cash Flow—47,371,000USD62,786,000USD48,985,000USD74,715,000USD84,246,000USD102,918,000USD119,166,000USD
    End Period Cash Flow—30,789,000USD47,371,000USD62,786,000USD67,131,000USD74,715,000USD84,246,000USD102,918,000USD
    Other Cashflows From Investing Activities—190,000USD-151,000USD-125,000USD——-103,000USD-42,000USD
    Other Cashflows From Financing Activities—-283,000USD2,112,000USD27,654,000USD—113,000USD88,000USD-5,467,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20262026-03-31 · USDFY 20252025-03-31 · USDFY 20242024-03-31 · USDFY 20232023-03-31 · USDFY 20222022-03-31 · USDFY 20212021-03-31 · USDFY 20202020-03-31 · USDFY 20192019-03-31 · USD
    Net Income-69,685,000USD-51,418,000USD-29,362,000USD-59,247,700USD-47,762,400USD-17,934,200USD-20,774,000USD-24,589,600USD
    Depreciation733,000USD635,000USD568,000USD531,200USD711,100USD117,600USD103,100USD91,200USD
    Stock Based Compensation3,997,000USD4,315,000USD2,182,000USD3,336,400USD3,480,700USD2,306,100USD3,820,800USD3,443,400USD
    Other Non Cash Items-543,000USD-389,000USD6,000USD-929,163,200USD232,000USD-97,682,600USD105,900USD4,663,800USD
    Change In Working Capital-938,000USD4,760,000USD793,000USD2,028,200USD-1,917,900USD3,437,000USD160,300USD1,718,200USD
    Total Cash From Operating Activities-66,436,000USD-42,097,000USD-25,813,000USD-49,715,100USD-45,256,500USD-12,073,500USD-15,757,000USD-14,527,500USD
    Capital Expenditures-151,000USD-191,000USD-61,000USD-212,000USD-200,400USD-275,400USD-275,400USD-174,000USD
    Free Cash Flow-66,436,000USD-42,288,000USD-25,874,000USD-49,927,100USD-45,456,900USD-12,348,900USD-15,757,000USD-14,701,500USD
    Investments-726,000USD-13,148,000USD-61,000USD-740,300USD-200,400USD-275,400USD-98,800USD-174,000USD
    Total Cashflows From Investing Activities-877,000USD-13,148,000USD-61,000USD-740,300USD-200,400USD-275,400USD-275,400USD-174,000USD
    Net Borrowings95,000USD0USD-985,000USD-1,034,000USD-3,000USD-382,000USD-296,600USD-223,200USD
    Total Cash From Financing Activities30,971,000USD3,210,000USD128,402,000USD-1,042,300USD10,483,900USD114,102,100USD4,011,800USD17,423,500USD
    Issuance Of Capital Stock30,645,000USD3,009,000USD129,379,000USD104,400USD4,279,500USD109,474,600USD3,598,400USD17,041,000USD
    Change In Cash-36,342,000USD-52,035,000USD102,528,000USD-51,497,700USD-34,973,000USD101,753,200USD-11,745,200USD2,722,000USD
    Begin Period Cash Flow67,131,000USD119,166,000USD16,638,000USD68,135,300USD103,108,300USD1,355,100USD13,100,300USD10,378,300USD
    End Period Cash Flow30,789,000USD67,131,000USD119,166,000USD16,637,600USD68,135,300USD103,108,300USD1,355,100USD13,100,300USD
    Other Cashflows From Investing Activities-151,000USD——-740,300,000USD-200,400,000USD-275,400,000USD—-174,000,000USD
    Other Cashflows From Financing Activities30,971,000USD201,000USD8,000USD867,026,200USD6,207,400USD5,233,900USD710,000USD1,157,326,200USD
    Unclassified Financing Cash Flow-30,740,000USD———4,279,500USD109,250,200USD3,598,400USD-1,139,679,500USD
    Change To Liabilities———0USD1,686,900USD3,718,900USD-390,700USD1,338,700USD
    Dividends Paid———-866,963,100USD-945,100,000USD-1,385,600,000USD-1,263,600,000USD-1,139,900,000USD
    Sale Purchase Of Stock———-173,900USD945,100,000USD1,385,600,000USD1,263,600,000USD1,139,900,000USD
    Unclassified Operating Cash Flow———932,800,000USD—97,682,600USD——
    Unclassified Investing Cash Flow———740,512,000USD200,600,400USD275,675,400USD—174,174,000USD
    Cash And Cash Equivalents Changes————-34,973,000USD101,753,200USD-11,745,200USD2,722,000USD
    Change To Account Receivables—————-40,600USD300,000USD-300,000USD
    Change To Inventory—————-51,000,000USD390,700,000USD-20,772,300USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    No revenue breakdown is currently published for this company.

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.